Yayın: Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4‐hydroxy‐3,5‐dimethoxy benzaldehyde motif
| dc.contributor.author | Demir, Yeliz | |
| dc.contributor.author | Türkeş, Cüneyt | |
| dc.contributor.author | Çavuş, Muhammet S. | |
| dc.contributor.author | Erdoğan, Musa | |
| dc.contributor.author | Muğlu, Halit | |
| dc.contributor.author | Yakan, Hasan | |
| dc.contributor.author | Beydemir, Şükrü | |
| dc.date.accessioned | 2026-01-05T23:04:49Z | |
| dc.date.issued | 2022-12-27 | |
| dc.description.abstract | AbstractNew Schiff base‐bearing thiosemicarbazones (1–13) were obtained from 4‐hydroxy‐3,5‐dimethoxy benzaldehyde and various isocyanates. The structures of the synthesized molecules were elucidated in detail. Density functional theory calculations were also performed to determine the spectroscopic properties of the compounds. Moreover, the enzyme inhibition activities of these compounds were investigated. They showed highly potent inhibition effects on acetylcholinesterase (AChE) and human carbonic anhydrases (hCAs) (KI values are in the range of 51.11 ± 6.01 to 278.10 ± 40.55 nM, 60.32 ± 9.78 to 300.00 ± 77.41 nM, and 64.21 ± 9.99 to 307.70 ± 61.35 nM for AChE, hCA I, and hCA II, respectively). In addition, molecular docking studies were performed, confirmed by binding affinities studies of the most potent derivatives. | |
| dc.description.uri | https://doi.org/10.1002/ardp.202200554 | |
| dc.description.uri | https://pubmed.ncbi.nlm.nih.gov/36575148 | |
| dc.description.uri | https://hdl.handle.net/11552/2989 | |
| dc.identifier.doi | 10.1002/ardp.202200554 | |
| dc.identifier.eissn | 1521-4184 | |
| dc.identifier.issn | 0365-6233 | |
| dc.identifier.openaire | doi_dedup___::67f2d8988cb48bc8ad0b040306b4bfbd | |
| dc.identifier.orcid | 0000-0003-3216-1098 | |
| dc.identifier.orcid | 0000-0002-3721-0883 | |
| dc.identifier.orcid | 0000-0001-6097-2862 | |
| dc.identifier.orcid | 0000-0001-8306-2378 | |
| dc.identifier.orcid | 0000-0002-4428-4696 | |
| dc.identifier.orcid | 0000-0003-3667-6902 | |
| dc.identifier.pubmed | 36575148 | |
| dc.identifier.scopus | 2-s2.0-85145266945 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12597/43554 | |
| dc.identifier.volume | 356 | |
| dc.identifier.wos | 000903773400001 | |
| dc.language.iso | eng | |
| dc.publisher | Wiley | |
| dc.relation.ispartof | Archiv der Pharmazie | |
| dc.rights | OPEN | |
| dc.subject | Thiosemicarbazones | |
| dc.subject | Carbonic Anhydrase I | |
| dc.subject | Enzyme Inhibition | |
| dc.subject | Molecular Structure | |
| dc.subject | DFT | |
| dc.subject | Carbonic Anhydrase II | |
| dc.subject | Molecular Docking | |
| dc.subject | Spectroscopic Elucidation | |
| dc.subject | Molecular Docking Simulation | |
| dc.subject | Structure-Activity Relationship | |
| dc.subject | Benzaldehydes | |
| dc.subject | Acetylcholinesterase | |
| dc.subject | Humans | |
| dc.subject | Cholinesterase Inhibitors | |
| dc.subject | Carbonic Anhydrase Inhibitors | |
| dc.subject | Density Functional Theory | |
| dc.title | Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4‐hydroxy‐3,5‐dimethoxy benzaldehyde motif | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.import.source | OpenAire | |
| local.indexed.at | WOS | |
| local.indexed.at | Scopus | |
| local.indexed.at | PubMed |
